Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06PHH
|
|||
Former ID |
DIB007628
|
|||
Drug Name |
Rimacalib
|
|||
Synonyms |
SMP-114
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Rheumatoid arthritis [ICD-11: FA20] | Phase 2 | [1] | |
Company |
Sumitomo Pharmaceuticals Co Ltd
|
|||
Structure |
Download2D MOL |
|||
Formula |
C22H23FN4O2
|
|||
Canonical SMILES |
CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C3=NOC(=C3)N=C(N)N4CCOCC4
|
|||
InChI |
1S/C22H23FN4O2/c1-15(17-7-8-18(19(23)13-17)16-5-3-2-4-6-16)20-14-21(29-26-20)25-22(24)27-9-11-28-12-10-27/h2-8,13-15H,9-12H2,1H3,(H2,24,25)/t15-/m0/s1
|
|||
InChIKey |
MYTIJGWONQOOLC-HNNXBMFYSA-N
|
|||
CAS Number |
CAS 215174-50-8
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | CaMKII inhibitors: from research tools to therapeutic agents. Front Pharmacol. 2014; 5: 21. | |||
REF 2 | Role for CaMKII inhibition in rheumatoid arthritis: effects on HIF-1-induced VEGF production by rheumatoid synovial fibroblasts. Ann N Y Acad Sci. 2009 Sep;1173:706-11. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.